| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ... New England Journal of Medicine 369 (18), 1691-1703, 2013 | 6625 | 2013 |
| Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung … MA Socinski, I Bondarenko, NA Karaseva, AM Makhson, I Vynnychenko, ... J Clin Oncol 30 (17), 2055-2062, 2012 | 871 | 2012 |
| Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ... Journal of clinical oncology 22 (1), 157-165, 2004 | 675 | 2004 |
| Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases MP Mehta, P Rodrigus, CHJ Terhaard, A Rao, J Suh, W Roa, L Souhami, ... Journal of Clinical Oncology 21 (13), 2529-2536, 2003 | 542 | 2003 |
| Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Li, SM Bentzen, M Renschler, MP Mehta Journal of Clinical Oncology 25 (10), 1260-1266, 2007 | 392 | 2007 |
| Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer J von Pawel, R Jotte, DR Spigel, MER O'Brien, MA Socinski, J Mezger, ... Journal of clinical oncology 32 (35), 4012-4019, 2014 | 327 | 2014 |
| Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis J Li, SM Bentzen, J Li, M Renschler, MP Mehta International Journal of Radiation Oncology* Biology* Physics 71 (1), 64-70, 2008 | 320 | 2008 |
| The emerging role of reactive oxygen species in cancer therapy MF Renschler European Journal of Cancer 40 (13), 1934-1940, 2004 | 273 | 2004 |
| Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas … DD Von Hoff, TJ Ervin, FP Arena, EG Chiorean, JR Infante, MJ Moore, ... Journal of Clinical Oncology 31 (4_suppl), LBA148-LBA148, 2013 | 183 | 2013 |
| Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based … R Jotte, P Conkling, C Reynolds, MD Galsky, L Klein, JF Fitzgibbons, ... Journal of clinical oncology 29 (3), 287-293, 2011 | 174 | 2011 |
| Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non–small-cell lung cancer patients with brain metastases: results … MP Mehta, WR Shapiro, SC Phan, R Gervais, C Carrie, P Chabot, ... International Journal of Radiation Oncology* Biology* Physics 73 (4), 1069-1076, 2009 | 172 | 2009 |
| Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging … MP Mehta, WR Shapiro, MJ Glantz, RA Patchell, MA Weitzner, CA Meyers, ... Journal of clinical oncology 20 (16), 3445-3453, 2002 | 168 | 2002 |
| A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging DI Rosenthal, P Nurenberg, CR Becerra, EP Frenkel, DP Carbone, ... Clinical cancer research 5 (4), 739-745, 1999 | 158 | 1999 |
| Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases P Carde, R Timmerman, MP Mehta, CD Koprowski, J Ford, RB Tishler, ... Journal of Clinical Oncology 19 (7), 2074-2083, 2001 | 153 | 2001 |
| Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer DS Ettinger, R Jotte, P Lorigan, V Gupta, L Garbo, C Alemany, P Conkling, ... Journal of Clinical Oncology 28 (15), 2598-2603, 2010 | 142 | 2010 |
| In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer RA Miller, K Woodburn, Q Fan, MF Renschler, JL Sessler, JA Koutcher International Journal of Radiation Oncology* Biology* Physics 45 (4), 981-989, 1999 | 139 | 1999 |
| Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer MA Socinski, CJ Langer, I Okamoto, JK Hon, V Hirsh, SR Dakhil, RD Page, ... Annals of Oncology 24 (2), 314-321, 2013 | 136 | 2013 |
| Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin) SG Rockson, P Kramer, M Razavi, A Szuba, S Filardo, P Fitzgerald, ... Circulation 102 (19), 2322-2324, 2000 | 129 | 2000 |
| Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma. MF Renschler, RR Bhatt, WJ Dower, R Levy Proceedings of the National Academy of Sciences 91 (9), 3623-3627, 1994 | 104 | 1994 |
| Neurocognitive and functional assessment of patients with brain metastases: a pilot study MA Herman, I Tremont-Lukats, CA Meyers, DD Trask, C Froseth, ... American journal of clinical oncology 26 (3), 273-279, 2003 | 94 | 2003 |
